We are live on ! Find out more
EC

Elequin Capital Portfolio holdings

AUM $1.19B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+0.92%
1 Year Est. Return
+16.08%
3 Year Est. Return
+46.25%
5 Year Est. Return
10 Year Est. Return
AUM
$355M
AUM Growth
+$88M
Cap. Flow
-$58.3M
Cap. Flow %
-16.41%
Top 10 Hldgs %
58.86%
Holding
966
New
409
Increased
69
Reduced
50
Closed
347
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFAC
901
DELISTED
Arena Fortify Acquisition Corp. Class A Common Stock
AFAC
-700
Closed -$7K
ZWRK
902
DELISTED
Z-Work Acquisition Corp. Class A Common Stock
ZWRK
-2,606
Closed -$26K
FSSI
903
DELISTED
Fortistar Sustainable Solutions Corp. Class A Common Stock
FSSI
-1,700
Closed -$17K
CLRM
904
DELISTED
Clarim Acquisition Corp. Class A Common Stock
CLRM
-1,019
Closed -$10K
HTPA
905
DELISTED
Highland Transcend Partners I Corp.
HTPA
-2,500
Closed -$25K
MACC
906
DELISTED
Mission Advancement Corp.
MACC
-5,214
Closed -$51K
REVH
907
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
-7,000
Closed -$69K
REVHW
908
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Warrant.
REVHW
-23,010
Closed -$1K
NDAC
909
DELISTED
NightDragon Acquisition Corp. Class A Common stock
NDAC
-61,804
Closed -$607K
OHPA
910
DELISTED
Orion Acquisition Corp. Class A common stock
OHPA
-800
Closed -$8K
SWET
911
DELISTED
Athlon Acquisition Corp. Class A Common stock
SWET
-500
Closed -$5K
TMAC
912
DELISTED
The Music Acquisition Corporation
TMAC
-2,000
Closed -$20K
TSIB
913
DELISTED
Tishman Speyer Innovation Corp. II Class A common stock
TSIB
-1,000
Closed -$10K
LMACA
914
DELISTED
Liberty Media Acquisition Corporation Series A Common Stock
LMACA
-619
Closed -$6K
CRU
915
DELISTED
Crucible Acquisition Corporation
CRU
-902
Closed -$9K
PHIC
916
DELISTED
Population Health Investment Co., Inc. Class A Ordinary Share
PHIC
-283
Closed -$3K
FRW
917
DELISTED
PWP Forward Acquisition Corp. I Class A Common Stock
FRW
-955
Closed -$9K
ASZ
918
DELISTED
Austerlitz Acquisition Corporation II
ASZ
-131,620
Closed -$1.29M
FVT
919
DELISTED
Fortress Value Acquisition Corp. III
FVT
-1,000
Closed -$10K
FVIV
920
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
-1,200
Closed -$12K
FLAC
921
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
-2,800
Closed -$28K
AUS
922
DELISTED
Austerlitz Acquisition Corporation I
AUS
-70,368
Closed -$690K
KIII
923
DELISTED
Kismet Acquisition Three Corp. Class A Ordinary Shares
KIII
-1,200
Closed -$12K
IACC
924
DELISTED
ION Acquisition Corp 3 Ltd.
IACC
-250
Closed -$2K
THCA
925
DELISTED
Tuscan Holdings Corp. II Common Stock
THCA
-12,063
Closed -$125K

Similar funds

Elequin Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Elequin Capital held 966 positions worth $355M, up 33% from $267M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Elequin Capital withdrew a net $58.3M in Q4 2022, closing 347 positions and reducing 50 holdings. Its most notable exit was Stanley Black & Decker, Inc., an estimated $41.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 12% of assets, down from 14% a quarter earlier, followed by Real Estate and Healthcare.

Against the trend, Elequin Capital opened a new position in State Street SPDR Bloomberg Convertible Securities ETF worth $9.9M.

  • Elequin Capital's largest Q4 2022 buy was State Street SPDR Bloomberg Convertible Securities ETF: 153,900 shares worth $9.9M.
  • Elequin Capital added most to Elanco Animal Health Incorporated 5.00% Tangible Equity Units in Q4 2022, an estimated $3.26M increase.
  • Elequin Capital's biggest Q4 2022 reduction was South Jersey Industries, Inc. Corporate Units, cutting an estimated $29.4M.
  • Elequin Capital fully exited Stanley Black & Decker, Inc. in Q4 2022, selling an estimated $41.1M.
  • Elequin Capital's ten largest holdings make up 59% of its $355M portfolio in Q4 2022.
  • Elequin Capital opened 409 new positions and closed 347 in Q4 2022.
  • Elequin Capital's portfolio value rose 33% quarter-over-quarter to $355M.

Based on Elequin Capital's 13F filing for Q4 2022, filed 9 Feb 2023.